Biodexa Pharmaceuticals Plc ADR [NASDAQ: BDRX] jumped around 0.58 points on Friday, while shares priced at $1.30 at the close of the session, up 79.36%. Compared to the average trading volume of 2.10M shares, BDRX reached a trading volume of 70247610 in the most recent
Biodexa Pharmaceuticals Plc ADR [NASDAQ: BDRX] price surged by 88.59 percent to reach at $0.76. The company report on March 28, 2024 at 8:15 AM that Biodexa’s MTX110 Shows Promise In Extending Life Expectancy Against Aggressive Brain Cancers. Topline Results For Progression-Free Survival Expected In
Biodexa Pharmaceuticals Plc ADR [NASDAQ: BDRX] gained 24.14% or 0.35 points to close at $1.80 with a heavy trading volume of 11884324 shares. The company report on February 8, 2024 at 8:30 AM that Biodexa Reports 12 Month Survival in MAGIC-G1 Study of MTX110 in
Biodexa Pharmaceuticals Plc ADR [NASDAQ: BDRX] plunged by -$0.18 during the normal trading session on while it closed the day at $1.35. The company report on February 7, 2024 at 8:30 AM that Biodexa Announces Allowance of U.S. Patent Covering Tolimidone. Biodexa Pharmaceuticals PLC. Biodexa
© 2024, Powered by Smart TechOne
